Chugai Pharmaceutical Co., Ltd.
CHGCF
Price:
$49.43
Market Cap:
$12.36T
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; osteoporosis, including Actemra, Edirol, and Bonviva; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neurosci...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2012-08-03
Stock Exchange
OTC
Ticker
CHGCF
PE Ratio
[27.61]
ROE
[22.29%]
Current Ratio
[7.28]
Dividend Yield
[1.30%]
Enterprise Value
[11.95T]
Dividend History
The Current Ratio as of June 2025 (TTM) for Chugai Pharmaceutical Co., Ltd. (CHGCF) is 7.28
According to Chugai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 7.28. This represents a change of 22.36% compared to the average of 5.95 of the last 4 quarters.
Chugai Pharmaceutical Co., Ltd. (CHGCF) Historical Current Ratio (quarterly & annually)
How has CHGCF Current Ratio performed in the past?
The mean historical Current Ratio of Chugai Pharmaceutical Co., Ltd. over the last ten years is 4.24. The current 7.28 Current Ratio has changed 17.07% with respect to the historical average. Over the past ten years (40 quarters), CHGCF's Current Ratio was at its highest in in the March 2025 quarter at 7.28. The Current Ratio was at its lowest in in the December 2022 quarter at 3.15.
Average
4.24
Median
4.35
Minimum
3.15
Maximum
5.53
Chugai Pharmaceutical Co., Ltd. (CHGCF) Current Ratio by Quarter and Year
Discovering the peaks and valleys of Chugai Pharmaceutical Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 50.31%
Maximum Annual Current Ratio = 5.53
Minimum Annual Increase = -12.05%
Minimum Annual Current Ratio = 3.15
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 5.53 | 16.67% |
| 2023 | 4.74 | 50.31% |
| 2022 | 3.15 | -2.91% |
| 2021 | 3.25 | -8.15% |
| 2020 | 3.54 | -9.38% |
| 2019 | 3.90 | -12.05% |
| 2018 | 4.44 | -8.96% |
| 2017 | 4.87 | 4.16% |
| 2016 | 4.68 | 9.68% |
| 2015 | 4.27 | -9.46% |
Chugai Pharmaceutical Co., Ltd. (CHGCF) Average Current Ratio
How has CHGCF Current Ratio performed in the past?
The current Current Ratio of Chugai Pharmaceutical Co., Ltd. (CHGCF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.48
5-year avg
4.04
10-year avg
4.24
Chugai Pharmaceutical Co., Ltd. (CHGCF) Current Ratio vs. Peers
How is CHGCF’s Current Ratio compared to its peers?
Chugai Pharmaceutical Co., Ltd.’s Current Ratio is greater than Merck & Co., Inc. (1.41), greater than Pfizer Inc. (1.26), greater than Johnson & Johnson (1.26), greater than AbbVie Inc. (0.76), greater than Bristol-Myers Squibb Company (1.28), greater than Eli Lilly and Company (1.37),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.41 | $201.28B | |
| 1.26 | $136.62B | |
| 1.26 | $364.09B | |
| 0.76 | $324.59B | |
| 1.28 | $95.49B | |
| 1.37 | $730.36B |
Build a custom stock screener for Chugai Pharmaceutical Co., Ltd. (CHGCF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chugai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Chugai Pharmaceutical Co., Ltd. (CHGCF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Chugai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is Chugai Pharmaceutical Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for Chugai Pharmaceutical Co., Ltd. (CHGCF)?
What is the highest Current Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCF)?
What is the 3-year average Current Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCF)?
What is the 5-year average Current Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCF)?
How does the current Current Ratio for Chugai Pharmaceutical Co., Ltd. (CHGCF) compare to its historical average?